Mario L. Suvà

24.7k citations

47 papers · 4.4k indexed · 4 hit papers · h-index 21

Impact in

Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Genetics top 1%
- Glioma Diagnosis and Treatment

Papers in

Genetics 23
- Glioma Diagnosis and Treatment 23
Cancer Research 13
- Cancer Genomics and Diagnostics 7
- MicroRNA in disease regulation 4

Co-authors: B Bernstein Itay Tirosh Nicolò Riggi Shawn Gillespie William Flavahan Brian B. Liau Andrew S. Venteicher Anat Stemmer‐Rachamimov
Journals: Neuro-Oncology (8 papers)Science (3 papers)Cancer Cell (3 papers)Neurosurgery (2 papers)Nature (2 papers)
Partner nations: United States Israel Switzerland

In The Last Decade

Mario L. Suvà

44 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Ewing’s Sarcoma 2021 · 175 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 New England Journal of Medicine
2015 Nature
2015 Science
2013 Science

Peers

Countries citing papers authored by Mario L. Suvà

Since Specialization

Citations

This map shows the geographic impact of Mario L. Suvà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario L. Suvà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario L. Suvà more than expected).

Fields of papers citing papers by Mario L. Suvà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario L. Suvà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario L. Suvà. The network helps show where Mario L. Suvà may publish in the future.

Co-authors

The 25 scholars most cited alongside Mario L. Suvà, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mario L. Suvà Line = papers co-authored together Mario L. Suvà links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Programs, origins and immunomodulatory functions of myeloid cells in glioma Nature ·Tyler E. Miller, Chadi A. El Farran, Charles Couturier, Zeyu Chen, Joshua P. D’Antonio, Julia A. Verga, Martin Arreola Villanueva, L. Nicolas Gonzalez Castro, Yuzhou Evelyn Tong, Tariq Al‐Saadi, A. Chiocca, Yuanyuan Zhang, David S. Fischer, Dieter Henrik Heiland, Jennifer L. Guerriero, Kevin Petrecca, Mario L. Suvà, Alex K. Shalek, B Bernstein	2025	17
2	TMET-30. Uncovering the metabolic programs underlying malignant cell state heterogeneity in glioblastoma Neuro-Oncology ·Alexander Jucht, Maolin Ge, Rony Chanoch-Myers, Florian Ruiz, Gerard Baquer, Alissa Greenwald, Min Yang, Toshiro Hara, Yilin Fan, Channing Pooley, Demi Gerovasilis, Charles Couturier, Nathalie Y.R. Agar, Itay Tirosh, Liron Bar‐Peled, Mario L. Suvà	2025	0
3	A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations Genome Medicine ·L. Nicolas Gonzalez Castro, Avishai Gavish, Lillian Bussema, Christopher Mount, Cyril Neftel, Masashi Nomura, E. Antonio Chiocca, Wenya Linda Bi, Omar Arnaout, Fred G. Barker, Justin M. Brown, Justin T. Jordan, Tracy T. Batchelor, Anat Stemmer‐Rachamimov, Scott R. Plotkin, Itay Tirosh, Mario L. Suvà	2025	1
4	Oncogenic IDH1 ^mut drives robust loss of histone acetylation and increases chromatin heterogeneity Proceedings of the National Academy of Sciences ·Noa Furth, Niv Cohen, Avishay Spitzer, Tomer‐Meir Salame, Bareket Dassa, Tevie Mehlman, Alexander Brandis, Arieh Moussaieff, Dinorah Friedmann‐Morvinski, María G. Castro, Jérôme Fortin, Mario L. Suvà, Itay Tirosh, Ayelet Erez, G. Ron, Efrat Shema	2024	2
5	Evolving cell states and oncogenic drivers during the progression of IDH-mutant gliomas Nature Cancer ·Jingyi Wu, L. Nicolas Gonzalez Castro, Sofia Battaglia, Chadi A. El Farran, Joshua P. D’Antonio, Tyler E. Miller, Mario L. Suvà, B Bernstein	2024	10
6	Glioblastoma Cortical Organoids Recapitulate Cell-State Heterogeneity and Intercellular Transfer Cancer Discovery ·Vamsi Mangena, Rony Chanoch-Myers, Rafaela Sartore, Bruna Paulsen, Simon Gritsch, Hannah Weisman, Toshiro Hara, Xandra O. Breakefield, Koen Breyne, Aviv Regev, Kwanghun Chung, Paola Arlotta, Itay Tirosh, Mario L. Suvà	2024	8
7	Targeting of the CD161 inhibitory receptor enhances T-cell–mediated immunity against hematological malignancies Blood ·Francesca Alvarez‐Calderon, Byong H. Kang, Oleksandr Kyrysyuk, Shiwei Zheng, Hao Wang, Nathan D. Mathewson, Adrienne Luoma, Xiaohan Ning, Jason W. Pyrdol, Xuan Cao, Mario L. Suvà, Guo‐Cheng Yuan, K. Dane Wittrup, Kai W. Wucherpfennig	2023	12
8	A map of tumor–host interactions in glioma at single-cell resolution GigaScience ·Francesca Pia Caruso, Luciano Garofano, Fulvio D’Angelo, Kai Yu, Fuchou Tang, Jinzhou Yuan, Jing Zhang, Luigi Cerulo, Stefano Maria Pagnotta, Davide Bedognetti, Peter A. Sims, Mario L. Suvà, Xiaodong Su, Anna Lasorella, Antonio Iavarone, Michele Ceccarelli	2020	31
9	The Glioma Stem Cell Model in the Era of Single-Cell Genomics Cancer Cell ·Mario L. Suvà, Itay Tirosh	2020	172
10	Histone Variant and Cell Context Determine H3K27M Reprogramming of the Enhancer Landscape and Oncogenic State Molecular Cell ·Surya Nagaraja, Michael A. Quezada, Shawn Gillespie, Marlene Arzt, James Lennon, Pamelyn J. Woo, Volker Hovestadt, Madhuri Kambhampati, Mariella G. Filbin, Mario L. Suvà, Javad Nazarian, Michelle Monje	2019	101
11	Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma Acta Neuropathologica Communications ·Grant L. Lin, Surya Nagaraja, Mariella G. Filbin, Mario L. Suvà, Hannes Vogel, Michelle Monje	2018	126
12	Dissecting hematopoietic and renal cell heterogeneity in adult zebrafish at single-cell resolution using RNA sequencing The Journal of Experimental Medicine ·Qin Tang, Sowmya Iyer, Riadh Lobbardi, John C. Moore, Huidong Chen, Caleb A. Lareau, Christine Hebert, McKenzie Shaw, Cyril Neftel, Mario L. Suvà, Craig J. Ceol, André Bernards, Martin J. Aryee, Luca Pinello, Iain A. Drummond, David M. Langenau	2017	141
13	Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance Cell stem cell ·Brian B. Liau, Cem Sievers, Laura K. Donohue, Shawn Gillespie, William Flavahan, Tyler E. Miller, Andrew S. Venteicher, Christine H. Hebert, Christopher D. Carey, Scott J. Rodig, Sarah J. Shareef, Fadi J. Najm, Peter van Galen, Hiroaki Wakimoto, Daniel P. Cahill, Jeremy N. Rich, Jon C. Aster, Mario L. Suvà, Anoop P. Patel, B Bernstein	2016	354
14	Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors Science ·Rachel Litman Flynn, Kelli E. Cox, Maya Jeitany, Hiroaki Wakimoto, Alysia R. Bryll, Neil J. Ganem, Francesca Bersani, José Ramón Pineda, Mario L. Suvà, Cyril H. Benes, Daniel A. Haber, François D. Boussin, Lee Zou Hit paper breakdown →	2015	376
15	Insulator dysfunction and oncogene activation in IDH mutant gliomas Nature ·William Flavahan, Yotam Drier, Brian B. Liau, Shawn Gillespie, Andrew S. Venteicher, Anat Stemmer‐Rachamimov, Mario L. Suvà, B Bernstein Hit paper breakdown →	2015	867
16	Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma Science ·Anoop P. Patel, Itay Tirosh, John J. Trombetta, Alex K. Shalek, Shawn Gillespie, Hiroaki Wakimoto, Daniel P. Cahill, Brian V. Nahed, William T. Curry, R L Martuza, David N. Louis, Orit Rozenblatt–Rosen, Mario L. Suvà, Aviv Regev, B Bernstein	2014	186
17	Genetics and epigenetics of gliomas Swiss Medical Weekly ·Mario L. Suvà	2014	9
18	An Aberrant Transcription Factor Network Essential for Wnt Signaling and Stem Cell Maintenance in Glioblastoma Cell Reports ·Esther Rheinbay, Mario L. Suvà, Shawn Gillespie, Hiroaki Wakimoto, Anoop P. Patel, Mohd Shahid, Ozgur Oksuz, Samuel D. Rabkin, Robert L. Martuza, Miguel N. Rivera, David N. Louis, Simon Kasif, S. Andrew, B Bernstein	2013	197
19	A Tell-Tail Sign of Chromatin: Histone Mutations Drive Pediatric Glioblastoma Cancer Cell ·Esther Rheinbay, David N. Louis, B Bernstein, Mario L. Suvà	2012	19
20	Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells Genes & Development ·Michalina Janiszewska, Mario L. Suvà, Nicolò Riggi, Riekelt H. Houtkooper, Johan Auwerx, Virginie Clément‐Schatlo, Ivan Radovanovic, Esther Rheinbay, Paolo Provero, Ivan Stamenkovic	2012	376

About Mario L. Suvà

Mario L. Suvà is a scholar working on Genetics, Cancer Research, Aging, Biophysics and Molecular Biology, having authored 47 papers that have together received 4.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (23 papers), Single-cell and spatial transcriptomics (12 papers), Epigenetics and DNA Methylation (9 papers), Cancer Genomics and Diagnostics (7 papers), MicroRNA in disease regulation (4 papers), CAR-T cell therapy research (4 papers), Chromatin Remodeling and Cancer (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Cancer Research (1.4k citations), Genetics (946 citations), Molecular Biology (3.2k citations), Oncology (947 citations) and Immunology (559 citations). Mario L. Suvà has collaborated with scholars based in United States, Israel and Switzerland. Frequent co-authors include B Bernstein, Itay Tirosh, Nicolò Riggi, Shawn Gillespie, William Flavahan, Brian B. Liau, Andrew S. Venteicher, Anat Stemmer‐Rachamimov, Yotam Drier and Ivan Stamenkovic. Their work appears in journals such as Neuro-Oncology, Science, Cancer Cell, Neurosurgery and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact